OR WAIT null SECS
November 01, 2022
Metrics from the CPHI Annual Survey suggest that confidence in the global pharma market has risen significantly in the past year.
Purolite and Repligen have extended their existing ligand partnership through 2032.
Lonza has launched a new capsule to deliver acid-sensitive APIs to the intestine.
FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.
Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.
October 31, 2022
Thermo Fisher Experts will demonstrate its various capabilities at CPHI Frankfurt 2022.
Roquette has launched excipients PEARLITOL CR-H and PEARLITOL 200 GT.
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.
October 25, 2022
Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology
August 23, 2022
The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.